reference/14300449

Predicate	Object
contentType	Journal Article
endingPage	2018
issn	1570-159X
issueIdentifier	11
pageRange	2014-2018
publicationName	Current Neuropharmacology
startingPage	2014
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ad15fe4e172b35c3390b4192fe2c6c54 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3456ea87532d7e2616592e16190ff86c
bibliographicCitation	Kumar D, Ashraf GM, Hassan MI. Therapeutic Integrity of Microbiome-based Medicines in Neurodegenerative Disorders. Curr Neuropharmacol. 2022;20(11):2014–8. PMID: 35156584; PMCID: PMC9886841.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46d3596be39fc5c6491912424b3e32f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_728794612bc3426beae4055f3d28b422 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc1143d0c07508a45746a7a0bedad072
date	202211
identifier	https://doi.org/10.2174/1570159x20666220214113816 https://pubmed.ncbi.nlm.nih.gov/PMC9886841 https://pubmed.ncbi.nlm.nih.gov/35156584
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33799 https://portal.issn.org/resource/ISSN/1570-159X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Therapeutic Integrity of Microbiome-based Medicines in Neurodegenerative Disorders
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D064307 http://id.nlm.nih.gov/mesh/D019636Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801

Showing number of triples: 1 to 26 of 26.